D511-0395 Screening compound: 5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-N,N-dimethylbenzene-1-sulfonamide

D511-0395 Screening compound: 5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-N,N-dimethylbenzene-1-sulfonamide
D511-0395 Screening compound: 5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-N,N-dimethylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D511-0395
5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-N,N-dimethylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D511-0395

Molecular Formula

C23H26FN5O4S (C23 H26 FN5 O4 S)

Compound Name

5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-N,N-dimethylbenzene-1-sulfonamide

IUPAC name

5-{3-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1H-pyrazol-5-yl}-2-methoxy-NN-dimethylbenzene-1-sulfonamide

SMILES

CN(C)S(c(cc(cc1)-c2cc(C(N(CC3)CCN3c(cc3)ccc3F)=O)n[nH]2)c1OC)(=O)=O

InChI

InChI=1S/C23H26FN5O4S/c1-27(2)34(31,32)22-14-16(4-9-21(22)33-3)19-15-20(26-25-19)23(30)29-12-10-28(11-13-29)18-7-5-17(24)6-8-18/h4-9,14-15H,10-13H2,1-3H3,(H,25,26)

InChI Key

OSHKPISLAYJFQL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27590130

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.945

Distribution Coefficient, logD

2.945

Water Solubility, LogSw

-3.56

Polar Surface Area

83.931

Acid Dissociation Constant (pKa)

11.54

Base Dissociation Constant (pKb)

5.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

D511-0395 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D511-0395 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D511-0395?
Check Price and Availability of D511-0395, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D511-0395 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D511-0395
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D511-0395
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D511-0395 available by request